UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000012162
Receipt No. R000014219
Official scientific title of the study Adoptive immunotherapy using donor liver NK cells for preventing recurrence of hepatocellular carcinoma after liver transplantation
Date of disclosure of the study information 2013/10/29
Last modified on 2018/06/12 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Adoptive immunotherapy using donor liver NK cells for preventing recurrence of hepatocellular carcinoma after liver transplantation
Title of the study (Brief title) Liver NK cell immunotherapy for liver transplant patients with HCC
Region
Japan

Condition
Condition Hepatocellular carcinoma
Classification by specialty
Hepato-biliary-pancreatic surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To reduce the recurrence of HCC after liver transplantation
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Phase I

Assessment
Primary outcomes Recurrent free survival
Key secondary outcomes Overall survival
Rejection rate
Infection rate

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 Adoptive transfer of donor liver NK cells
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Adult liver transplant patients with HCC
Key exclusion criteria No HCC patients
Target sample size 50

Research contact person
Name of lead principal investigator Hideki Ohdan
Organization Hiroshima University
Division name Gastroenterology and transplant surgery
Address 1-2-3 Kasumi, Minamiku, Hiroshima
TEL 082-257-5222
Email hohdan@hiroshima-u.ac.jp

Public contact
Name of contact person Masahiro Ohira
Organization Hiroshima University
Division name Gastroenterology and transplant surgery
Address 1-2-3 Kasumi, Minamiku, Hiroshima
TEL 082-257-5222
Homepage URL
Email mohira@hiroshima-u.ac.jp

Sponsor
Institute Hiroshima University
Institute
Department

Funding Source
Organization Hiroshima University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 広島大学病院

Other administrative information
Date of disclosure of the study information
2013 Year 10 Month 29 Day

Progress
Recruitment status Completed
Date of protocol fixation
2005 Year 03 Month 16 Day
Anticipated trial start date
2006 Year 01 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2013 Year 10 Month 29 Day
Last modified on
2018 Year 06 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014219